View detailed stock price information for Aurinia Pharmaceuticals Inc [AUPH:US] from Trade AUPH:US Now Zacks , 4:16 PM EST December 10, 2019 Detailed price information for Aurinia Pharm Ord (AUPH-Q) from The Globe and Aurinia Pharmaceuticals stock surges on positive clinical results for lupus drug Corporate earnings are provided from Zacks Investment Research, including Top trades and best-performing strategies with Aurinia Pharmaceuticals Inc $AUPH supported by the most actionable news from the market. The latest closing stock price for Aurinia Pharmaceuticals Inc as of January 14, 2020 is 19.91. The all-time high Aurinia the last 52 weeks is 7.56. Compare AUPH With Other Stocks Fundamental data from Zacks Investment Research, Inc. Technical stock forecast for AUPH: Several short-term signals, along with a Zacks Investment Research is releasing its prediction for AUPH based on the 1-3
Close price at the end of the last trading day (Tuesday, 7th Jan 2020) of the AUPH stock was $21.36. This is 3.24% more than the trading day before Monday, 6th Jan 2020. During the day the stock fluctuated 6.09% from a day low at $20.52 to a day high of $21.77.
Equities research analysts forecast that Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) (TSE:AUP) will report sales of $40,000.00 for the current fiscal quarter, according to Zacks Investment Research. Four analysts have provided estimates for Aurinia Pharmaceuticals’ earnings, with estimates ranging from $10,000.00 to $100,000.00. Aurinia 04/06/2019 · Aurinia Pharmaceuticals (NASDAQ:AUPH) (TSE:AUP) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued on Tuesday, Zacks.com reports. According to Zacks, “Aurinia Pharmaceuticals Inc. is a late stage biopharmaceutical company. It focuses on the development of therapeutic Two analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. Aurinia Pharmaceuticals has an average rating of Buy and an average price target of $18.46. Shares of NASDAQ AUPH opened at $15.44 on Thursday. The firm has a market capitalization of $1.41 billion, a P/E ratio of -20.32 and a beta of 1.27. 23/09/2019 · Investors in Aurinia Pharmaceuticals Inc. AUPH need to pay close attention to the stock based on moves in the options market lately. That is because the Dec 20, 2019 $6.00 Put had some of the highest implied volatility of all equity options today. What is Implied Volatility? Implied volatility shows how much movement the market is Find the latest Aurinia Pharmaceuticals Inc (AUPH) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.
Aurinia Pharmaceuticals Inc Ordinary Shares (AUPH) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
View detailed financial information, real-time news, videos, quotes and analysis on Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH). Explore commentary on Aurinia Pharmaceuticals Inc. and hear what the experts at TheStreet are saying about AUPH. 01/01/2010 · CLVS, AUPH, ESTC and HOV among midday movers Seeking Alpha Dec 05, 2019; Aurinia Pharmaceuticals leads healthcare gainers; Sage Therapeutics leads the losers Seeking Alpha Dec 05, 2019; ACAD, PCG among premarket gainers Seeking Alpha Dec 05, 2019; Aurinia's Lupus Candidate Succeeds in Pivotal Study, Stock Up Zacks Dec 05, 2019 Zacks Investment Research upgraded shares of Aurinia Pharmaceuticals (NASDAQ:AUPH) (TSE:AUP) from a hold rating to a buy rating in a research report sent to investors on Tuesday, Zacks.com reports. They currently have $7.00 price target on the biotechnology company’s stock. According to Zacks, “Aurinia Pharmaceuticals Inc. is a late stage The latest closing stock price for Aurinia Pharmaceuticals Inc as of January 10, 2020 is 20.21. The all-time high Aurinia Pharmaceuticals Inc stock closing price was 21.46 on January 02, 2020. The Aurinia Pharmaceuticals Inc 52-week high stock price is 21.93, which is 8.5% above the current share price. Find real-time AUPH - Aurinia Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business.